1-4 of 4
Leisha A. Emens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Report on the Third FDA–AACR Oncology Dose-Finding Workshop

Leisha A. Emens, Rene Bruno, Eric H. Rubin, Elizabeth M. Jaffee, Amy E. McKee
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (12): 1058–1061.
https://doi.org/10.1158/2326-6066.CIR-17-0590
Published: 30 November 2017
View article titled, Report on the Third FDA–AACR Oncology Dose-Finding Workshop
Open the PDF for Report on the Third FDA–AACR Oncology Dose-Finding Workshop in another window
Journal Articles

A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice

Jeremy B. Foote, Marleen Kok, James M. Leatherman, Todd D. Armstrong, Bridget C. Marcinkowski, Laureen S. Ojalvo, David B. Kanne, Elizabeth M. Jaffee, Thomas W. Dubensky, Jr, Leisha A. Emens
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (6): 468–479.
https://doi.org/10.1158/2326-6066.CIR-16-0284
Published: 01 June 2017
View article titled, A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
Open the PDF for A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice in another window
Includes: Supplementary data
Journal Articles

The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies

Leisha A. Emens, Gary Middleton
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (5): 436–443.
https://doi.org/10.1158/2326-6066.CIR-15-0064
Published: 03 May 2015
View article titled, The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Open the PDF for The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies in another window
Journal Articles

A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer

Gang Chen, Richa Gupta, Silvia Petrik, Marina Laiko, James M. Leatherman, Justin M. Asquith, Maithili M. Daphtary, Elizabeth Garrett-Mayer, Nancy E. Davidson, Kellie Hirt, Maureen Berg, Jennifer N. Uram, Tianna Dauses, John Fetting, Elizabeth M. Duus, Saadet Atay-Rosenthal, Xiaobu Ye, Antonio C. Wolff, Vered Stearns, Elizabeth M. Jaffee, Leisha A. Emens
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (10): 949–961.
https://doi.org/10.1158/2326-6066.CIR-14-0058
Published: 02 October 2014
View article titled, A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2<sup>+</sup> Metastatic Breast Cancer
Open the PDF for A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2<sup>+</sup> Metastatic Breast Cancer in another window